| ²é¿´: 7529 | »Ø¸´: 60 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
¡¾×ªÔØ¡¿ÈçºÎÏòÍâÎÄÆÚ¿¯Í¶¸å
|
|||
|
http://www.medicalarticle.cn/07.htm ÊǶÔҽѧÂÛÎĶøÑԵ쬯äʵÆäËûרҵҲ²î²»¶à [ Last edited by 7654321 on 2005-12-2 at 00:55 ] |
» ²ÂÄãϲ»¶
ÉúÎïѧѧ˶Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ÉϺ£µçÁ¦´óѧ²ÄÁÏ·À»¤ÓëвÄÁÏÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÑо¿Éú£¨²ÄÁÏ¡¢»¯Ñ§¡¢µç»¯Ñ§£¬»·¾³£©
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
303Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÎäÀí085500»úеרҵ×Ü·Ö300Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ4È˻ظ´
281Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0805 316Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085601Çóµ÷¼Á×Ü·Ö293Ó¢Ò»Êý¶þ
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ17È˻ظ´
Ͷ¸å×¢ÒâÊÂÏî
|
Ͷ¸åǰµÄ×¼±¸ µ±¾ö¶¨ÁËÂÛÎĵÄÖ÷Ì⣬ȷ¶¨ÁËÂÛÎĵĶÁÕßȺ£¬²¢Ñ¡¶¨ÁËÂÛÎÄÄâͶÆÚ¿¯ºó£¬ÂÛÎĵÄÎÄÏ×¼ìË÷¹¤×÷±ãÍê³ÉÁË¡£ÏÂÒ»²½¾ÍÊÇÈ·¶¨ÂÛÎÄ×÷Õß¡¢²é¿´ÆÚ¿¯µÄ¡°Í¶¸åÐëÖª¡±£¬²¢½«Ñо¿½á¹ûµÄÔʼ×ÊÁÏÊÕ¼¯ÔÚÒ»Æð¿ªÊ¼×«Ð´ÂÛÎÄ¡£ÂÛÎÄ׫дÊÇÒ»Ïî¼è¿àµÄ¹¤×÷£¬²¢·ÇÒ»¸å¾ÍÄÜÍê³É£¬ÍùÍùÐèÒª·´¸´Ò׸壨Ð޸쩲ÅÄÜʹÎÄÕ´ﵽͶ¸åµÄÒªÇ󣬼´Ëùν"5C"¡ªÕýÈ·£¨correctness£©¡¢Çå³þ£¨clarity£©¡¢¼ò½à£¨concision£©¡¢ÍêÕû£¨completion£©ºÍÒ»ÖÂÐÔ£¨consistency£©¡£ ׫дÂÛÎijõ¸å£¨writing the first draft£© ׫д³õ¸åǰ³ýÐèÈÏÕæÔĶÁÄâͶÆÚ¿¯µÄ¡°Í¶¸åÐëÖª¡±£¬×ÐϸÑо¿ËùÑ¡ÆÚ¿¯¶ÔÂÛÎÄ׫дµÄ¸÷ÖÖÒªÇóÍ⣻»¹Ó¦ÈÏÕæÑ§Ï°×îгö°æµÄÄâͶÆÚ¿¯ÖÐÓë×Ô¼ºÂÛÎÄÏàËÆµÄÎÄÕ£¬¿´¡°ÐëÖª¡±ÖеÄÒªÇóÈçºÎÔÚÕâЩÎÄÕÂÖÐÌåÏÖ£¬²¢ÒÔÕâЩÎÄÕÂΪд×÷Ñù±¾¡£ ¶àÊýÓ¢ÎÄÉúÎïҽѧÆÚ¿¯ÒªÇó×÷ÕßÒÀ¾ÝÑо¿ÂÛÎĵıê×¼¸ñʽ£¬¼´IMRAD¸ñʽ¡ª¡ªÇ°ÑÔ£¨introduction£©¡¢·½·¨£¨methods£©¡¢½á¹ûºÍÌÖÂÛ£¨results and discussion£©×«Ð´ÂÛÎÄ¡£ÓоÑéµÄ¿ÆÑ§Ð´×÷¼Ò¶¼ÈÏΪ£¬×«Ð´ÂÛÎÄ´Ó¡°²ÄÁϺͷ½·¨¡±²¿·Ö¿ªÊ¼£¬ÒÔ¡°ÕªÒª¡¢ÎÄÌâ¡¢×÷Õß¡±½áÊø£¬¿ÉÒÔʹд×÷¸üΪ¿ì½Ý¶øÓÐЧ£¬²¢ÇÒ¿ÉÒÔÃ÷ÏÔ¼õÉÙÒÔºóµÄÐ޸Ť×÷¡£ÂÛÎĵÄ׫д²½Öè¼°¸÷²¿·ÖµÄÖ÷ÒªÌØµãÈçÏ£º (1)²ÄÁϺͷ½·¨£¨methods and materials£©£º×öÁËʲôºÍÔõÑù×ö£¿ ²ÄÁϺͷ½·¨ÊÇÎÄÕ¿ªÊ¼Ð´×÷µÄ×îÀíÏ벿·Ö£¬ÒòΪÕⲿ·ÖµÄÄÚÈÝ×÷Õß×îÁ˽⡣»ù±¾Ð´×÷ÒªÇó£ºÓùýȥʱ£¬¾¡¿ÉÄܰ´ÊµÑéÑо¿µÄÏȺó˳ÐòÃèÊö¡£ (2)½á¹û£¨results£©£º·¢ÉúÁËʲô£¿»ù±¾Ð´×÷ÒªÇó£º •Êý¾Ý¿ÉÓÃͼ¡¢±í»òÎÄ×Ö±í´ï£¬µ«ÈýÕß¼äÓ¦¾¡ÉÙÖØ¸´ •ÔÚÕýÎIJ¿·ÖÐðÊöÖ÷Òª½á¹ûºÍÒâÒ壬ÓÃͼ»ò±í¸ø³ö½ÏÏêϸµÄÊý¾Ý •Óùýȥʱ (3)ÌÖÂÛ£¨discussion£©£ºËù»ñµÃµÄ½á¹ûÊÇ·ñΪ¡°Ç°ÑÔ¡±ÖÐÌᣮ³öµÄ¹Ø¼üÎÊÌâµÄ´ð°¸£¿½á¹ûÈçºÎÖ§³Ö´ð°¸£¿»ù±¾Ð´×÷ÒªÇó£º •¼¯ÖÐÌÖÂÛÓë±¾½á¹ûÓйصÄÎÊÌ⣬ͻ³ö±¾Ñо¿µÄ´´Ð¼°ÖØÒªÐÔ£¬²¢ÓëÏà¹ØµÄÑо¿½á¹û½øÐÐ±È½Ï •¸ø³ö½á¹ûËùÖ§³ÖµÄ½áÂÛ •ÓÃÏÖÔÚʱÐðÊöÒÑÖª»ò±»Ö¤Ã÷µÄÊÂʵ£¬ÓùýȥʱÃèÊö±¾Ñо¿½á¹û (4)²Î¿¼ÎÄÏ×£¨references£©£ºÓë±¾Ñо¿·½·¨¡¢½á¹û¡¢ÌÖÂÛÓÐ¹ØµÄÆäËüÑо¿ÊÇʲô£¿ÆäÖøÂ¼ÒªÇóÊÇ£º×¼È·¡¢ÍêÕû¡¢¹æ·¶¡£ (5)ǰÑÔ£¨introduction£©±¾Ñо¿µÄ±³¾°ºÍÄ¿µÄÊÇʲô£¿±¾Ñо¿ÊÔͼ»Ø´ðµÄ¹Ø¼ü¼äÌâÊÇʲô£¿»ù±¾Ð´×÷ÒªÇó£º •±¾Ñо¿Ä¿µÄ¼°ÖØÒªÐÔ •¼òÒª¸´Ï°ÎÄÏ× (6)ÖÂл£¨acknowledgment£©£º³ýÁË×÷Õߣ¬ËÐÖúÍê³ÉÁ˱¾Ñо¿¡¢·ÖÎö½á¹û²¢×«Ð´ÂÛÎÄ£¿ËÌṩÁË»ù½ðºÍÎïÖʵİïÖú£¿»ù±¾Ð´×÷ÒªÇó£º •½öÁгö¶Ô±¾¹¤×÷Ìá¹©ÌØÊâµÄʵÖÊÐÔ¹±Ï×ÕßµÄÐÕÃû •±ØÐëµÃµ½±»ÖÂлÕßµÄͬÒâ (7)ÕªÒª£¨abstract£©£ºÂÛÎĸæËßÎÒÃÇʲô£¿£¨Í¨³£¡´250×Ö£© ÕªÒªÊÇÂÛÎÄÒªµãµÄŨËõ£¬Òò´ËÓ¦ÔÚÎÄÕ¸÷Ö÷Òª²¿·ÖÍê³ÉºóÔÙд£¬ÕâÑùÓÐÀûÓÚÎÄÕÂÒªµãµÄÌáÁ¶¡£ÓÅÐãµÄÕªÒªÄÜÓÐЧµØ×¥×¡¶ÁÕßµÄÐËȤ¡£»ù±¾Ð´×÷ÒªÇó£º •Óú¬ÓбØÒª´Ê»ãµÄ¶ÌµÄ¼òµ¥¾ä£¬ÒÔʹժҪÇå³þ¶ø¼ò½à•±ÜÃâʹÓÃËõд´ÊºÍ»ÞɬÄѶ®µÄ´Ê¾ä •ÓÃС±êÌâÐðÊöÑо¿ÂÛÎĵĸ÷²¿·Ö •Óùýȥʱ£¨µ«ÎÊÌâµÄ³ÂÊöºÍ½áÂÛ¿ÉÓÃÏÖÔÚʱ£© •Ç¿µ÷Ñо¿µÄ´´ÐºÍÖØÒª·½Ãæ £¨8£©ÎÄÌ⣨title£©£º±¾ÎĹØÓÚʲô£¿×î¼ÑÎÄÌâµÄ±ê×¼ÊÇÓÃ×îÉٵıØÒªÊõÓïȥ׼ȷÃèÊöÂÛÎĵÄÄÚÈÝ¡£»ù±¾Ð´×÷ÒªÇó£º×¼È·£¨accuracy£©¡¢¼ò½à£¨brevity£©ºÍÓÐЧ£¨effectiveness£©¡£ (9)×÷Õߣ¨author list£©£ºË²ÎÓëÁ˱¾Ñо¿µÄÉè¼Æ¡¢¹¤×÷¼°ÂÛÎĵÄ׫д£¿ ×¼±¸ÂÛÎÄ×îºóÒ»¸å£¨preparing the final manuscript£© ÂÛÎijõ¸åÍê³ÉÒԺ󣬱ØÐë¶ÔÆäÄÚÈݼ°¸ñʽ½øÐз´¸´µÄÍÆÇúÍÐ޸ģ¬ÒÔ´ïµ½¡°Í¶¸åÐëÖª¡±ËùÌá³öµÄÒ»ÇÐÒªÇó¡£ÓÈÆäÊÇͶ¸øÆÚ¿¯µÄ¸å¼þÒ»¶¨Òª´ïµ½ÆÚ¿¯ËùÒªÇóµÄ±à¼¸ñʽ£¬·ñÔò²»µ«²»Äܱ»½ÓÊÜ·¢±í£¬ÉõÖÁÓÚ¸ù±¾²»Ó迼ÂÇ¡£ÒòΪ¾ø´ó¶àÊýÓоÑéµÄ±à¼¶¼ÈÏΪ£º²»ÈÏÕæ×¼±¸µÄ¸å¼þ¾ø²»ÊǸßˮƽ¿ÆÑ§Ñо¿³É¹ûµÄÁ¼ºÃÔØÌ壨A poorly prepared manuscript is£¬almost without fail£¬the carrier vehicle of poor science. Day AR.£©¡£ËùÒÔ£¬Èç¹ûÏ£ÍûÂÛÎı»·¢±í£¬ÔÚ×¼±¸Í¶¸øÆÚ¿¯µÄ¸å¼þʱ±ØÐë×öµ½´ò×ÖÕû½à¡¢ÎÞ´í¡¢·ûºÏÆÚ¿¯¸ñʽ¡¢º¬ÓÐÆÚ¿¯ÒªÇóµÄËùÓвÄÁÏ¡£ ×¼±¸ÂÛÎÄ×îºóÒ»¸åÒ»°ã·ÖÈý²½£¬Ê×ÏÈÊÇÔÙ´ÎÔĶÁÄâͶÆÚ¿¯µÄ¡°Í¶¸åÐëÖª¡±£¬È»ºóÓá°Í¶¸åÐëÖª¡±ÖÐÌṩµÄ¡°¸å¼þ¶ÔÕÕ¼ì²é±í¡±(manuscript checklist, author's checklist)Óë×Ô¼ºµÄÂÛÎÄÒ»Ò»ºË¶Ô£¬×îºó¸ù¾ÝÆÚ¿¯ÒªÇó´ò×Ö£¬Íê³É×îºóÒ»¸å¡£ Ó¦Ö¸³öµÄÊÇ£¬²¢·ÇËùÓеÄÓ¢ÎÄÉúÎïҽѧÆÚ¿¯¾ùÌṩ¸å¼þ¶ÔÕÕ¼ì²é±í£¬¶øÇÒ¸÷ÖÖÆÚ¿¯ÌṩµÄ¸å¼þ¶ÔÕÕ¼ì²é±íµÄÄÚÈÝÏêÂÔ²»Ò»£¬ÈçBMJ¸½ÁË3¸ö½ÏΪÏêϸµÄ¶ÔÕÕ¼ì²é±í£¬·Ö±ð¹©Í¬ÐС¢Í³¼ÆÑ§Éó¸åר¼ÒºÍ¼¼Êõ±à¼Éó¸åºÍ±à¼¼Ó¹¤¸å¼þʱ¶ÔÕÕ¼ì²é£¬Í¬Ê±Ò²Ìṩ¸ø×÷ÕßÒÔ¹©×ÔÉí¶ÔÕÕ¼ì²é¡£JAMAµÄ¸å¼þ¼ì²é¶ÔÕÕ±í½Ï¼òµ¥£¬½ö13Ìõ£¬µ«Ö÷ÒªÄÚÈݾùÒѰüÀ¨ÆäÖС£¶ÔÓÚÎÞ¸å¼þ¼ì²é¶ÔÕÕ±íµÄ¡°Í¶¸åÐëÖª¡±£¬×÷Õ߿ɸù¾Ý¡°ÐëÖª¡±ÄÚÈÝ×Ô¼ºÄⶨ¼ì²é¶ÔÕÕ±í¡£ÏÖ½«¡¶ÃÀ¹úҽѧ»áÔÓÖ¾¡·£¨ÖÝMA£©µÄ¸å¼þ¶ÔÕÕ¼ì²é±í¾ÙÀýÈçÏ£º ¿Ú1.1·ÝÔ¸åºÍ3·Ý¿½±´¡£ ¿Ú2.ÎÄÌâÒ³½öÐè¸ø³öÕýÎÄ×ÖÊý£¬²»°üÀ¨ÎÄÌâ¡¢ÕªÒª¡¢²Î¿¼ÎÄÏס¢±íºÍͼעµÄ×ÖÊý¡£ ¿Ú3.ÓÉÿһλ×÷ÕßÇ©×ֵģ¨1)ÊðÃû×ʸñºÍÔðÈΣ¬(2)¾·Ñ¹«¿ª£¬(3)°æÈ¨×ªÈûòΪÁª°îÕþ¸®¹ÍÔ±µÄ3¸öÉùÃ÷¡£ ¿Ú4.ÓÉͨÐÅ×÷ÕßÇ©×ֵĻñµÃÖÂлÈËÊéÃæÍ¬Òâ²ÄÁϵÄÉùÃ÷¡£ ¿Ú5.ÔÚÖÂлÖÐÁгöÑо¿»òÏîÄ¿»ù½ð¡£ ¿Ú6.¸ôÐдò×Ö£¨ÕýÎĺͲο¼ÎÄÏ×£©£¬ÓÒÎÄÅԱ߽粻¶ÔÆë¡£ ¿Ú7.¼ì²éËùÓвο¼ÎÄÏ×£¬ÒÔÈ·±£×¼È·¡¢ÍêÕû¡£²ÉÓÃÊý×Ö±àÂëÖÆ£¬È·¶¨Ã¿Ò»ÎÄÏ×¾ùÔÚÎÄÖб»ÒýÓᣠ¿Ú8.4Ì×Ôͼ¡£ ¿Ú9.Ìṩ·ûºÏ¸ñʽҪÇóµÄÕªÒª¡£ ¿Ú10.ÒýÓÃ˽ÈËͨÐŵÄÊéÃæÍ¬Òâ²ÄÁÏ¡£ ¿Ú11.¶Ô¿É±æÈϲ¡ÈËÉí·ÝµÄÃèÊö¡¢ÕÕÆ¬¼°¼ÒÆ×£¬¸½Õ÷µÃÖªÇéͬÒâµÄ²ÄÁÏ¡£ ¿Ú12.Ô³ö°æÕßͬÒâÒýÓûòÐÞ¸ÄÆäÒÑ·¢±íͼºÍ±í¸ñµÄÊéÃæ²ÄÁÏ¡£ ¿Ú13.ÔÚÎÄÌâҳдÃ÷ͨÐÅ×÷Õߣ¬²¢ÌṩÆäÏêϸµØÖ·¡¢µç»°ºÍ´«ÕæºÅÂëÒÔ¼°e£mailµØÖ·¡£ Ͷ ¸å ÂÛÎĵÄ×îºóÒ»¸å°´¡°Í¶¸åÐëÖª¡±µÄÒªÇó×¼±¸ºÃÒԺ󣬾ͿÉÒÔÏò¹úÍâͶ¸åÁË¡£Ò»°ãÀ´Ëµ£¬Í¶¸å³ÌÐò·ÖÒÔÏÂÈý²½½øÐУº •×¼±¸Ò»·Ý¸½ÔÚ¸å¼þǰµÄͶ¸åÐÅ •¸å¼þ°ü×° •¸å¼þÓÊ¼Ä ×¼±¸Í¶¸åÐÅ£¨covering letter£¬submission letter£© ÉúÎïҽѧÆÚ¿¯µÄ±à¼ÍùÍùÐèҪһЩÓйØ×÷ÕߺÍ×÷ÕßÂÛÎĵÄÐÅÏ¢£¬¶ø×÷ÕßҲϣÍû¸ø±à¼ÌṩһЩÓÐÖúÓÚÆäÈ«ÎÄËÍÉó¼°¾ö²ßµÄÐÅÏ¢¡£ÕâЩÐÅÏ¢¶¼Ó¦¸Ã°üÀ¨ÔÚͶ¸åÐÅÖС£Í¶¸åÐÅÓ¦°üÀ¨ÒÔϼ¸·½ÃæµÄÄÚÈÝ£º •ÎÄÌâºÍËùÓÐ×÷ÕßµÄÐÕÃû •¸å¼þÊÊÒ˵ÄÀ¸Ä¿ •Ϊʲô´ËÂÛÎÄÊʺÏÓÚÔڸÿ¯¶ø²»ÊÇÆäËü¿¯ÎïÉÏ·¢±í•¹ØÓÚÖØ¸´»ò²¿·Ö·¢±í»òÒÑͶËü¿¯µÄ˵Ã÷ •²»ÄÜתÈðæÈ¨µÄ˵Ã÷£¨ÈçÃÀ¹úÁª°îÕþ¸®¹ÍÔ±£© •½¨ÒéÉó¸åÈ˼°Òò´æÔÚ¾ºÕù¹ØÏµ¶ø²»ÒË×öÉó¸åÈ˵ÄÃûµ¥ •ͨÐÅ×÷Õߣ¨corresponding author£©µÄÐÕÃû¡¢ÏêϸµØÖ·¡¢µç»°ºÍ´«ÕæºÅÂë¡¢e-mailµØÖ· •ÄÜ·ñ¸¶³ö°æ·Ñ£¨°æÃæ·Ñ¡¢²Êͼ·Ñ£©µÄ˵Ã÷£¨Èç¹û¸Ã¿¯ÊÕÈ¡°æÃæ·ÑºÍ²Êͼ·Ñ£© •Ï£ÍûºËУУÑù»ò¸å¼þÈô²»½ÓÊÕÍË»ØÔ¸åµÄÒªÇó£¨ÓÐµÄÆÚ¿¯ÔÚ¡°Í¶¸åÐëÖª¡±ÖÐÔ¼¶¨£¬³ý·Ç×÷ÕßÔÚͶ¸åÐÅÖÐÌá³öÒªÇ󣬷ñÔòԸ岻ÍË»¹¸ø×÷Õߣ© Ͷ¸åОÙÀý£º Dear Dr£®£º Enclosed are three copies of a manuscript by Rose N £®Dipaola£¬Donna A£®Gallo£¬and Tom N£®Roberts titled¡°Hepatitis C Virus Infection in Long-Term Transfusion Patients¡±£®It is submitted to be considered for publication as a¡°Original Article" in your journal£®This paper is¡«•Neither the entire paper nor any part of its content has been published or has been accepted elsewhere £®It is not being submitted to any other journal£® We believe the paper may be of particular interest to the readers of your journal because the study it reports stated the HCV infection rate among long-term transfusion patients is higher than that of the general population and of short-term transfusion patients£® Correspondence and phone calls about the paper should be directed to Rose N£®Dipaola at the following address£¬phone and fax number£¬and e-mail address£º Rose N £®Dipaola£¬MD Institute of Internal Medicine Cleveland Clinic Foundation 9500 Euclid Ave£® Cleveland£¬OH44195£¬USA Tel£º1-216-444-5360 Fax£º1-216-444-9580 E-mail£ºdipao£Àcesmtp £®ccf. Org Thanks very much for your attention to our paper£® Sincerely yours£¬ Rose N£®Dipaola ¸å¼þ°ü×° Ëùν¸å¼þ°ü×°ÊÇÖ¸½«¸å¼þ¼°ÆäÄâͶÆÚ¿¯ËùÐèµÄ°éËæ×ÊÁÏÒ»²¢×°ÈËÐÅ·â¡£Ò»°ãÓ¦°´ÒÔÏÂ˳Ðò±¸Æë×ÊÁÏ£º •Ͷ¸åÐÅ •¿¯ÎïÒªÇóµÄ¸å¼þ£¨°üÀ¨ÎÄÌâÒ³¡¢ÎÄÕªÒ³¡¢ÕýÎÄ¡¢ÖÂл¡¢²Î¿¼ÎÄÏס¢Í¼×¢¡¢±í¼°Í¼£©¿½±´·ÝÊý£¬Ã¿·Ýͼµ¥¶À×°Ò»¸öÐÅ·â •°æÈ¨×ªÈÃÉùÃ÷ •Óë¸å¼þÄÚÈÝÓйØ×ÊÁϵĿ½±´£¨ÈçѧÊõ»áÒ鱨¸æÂÛÎÄ»òÒÑ·¢±íµÄÕªÒªµÈ²ÄÁÏ£© •֪ͨ¸å¼þÊÕµ½µÄÃ÷ÐÅÆ¬»òÓÐ×÷ÕßµØÖ·²¢Ìù×ãÓÊ×ʵÄÐŷ⣨ÊÊÓÃÓÚ²»·¢ÊՏ廨ִµÄÆÚ¿¯£© •ÖÂлºÍʹÓò¡ÈËÕÕÆ¬»òÒýÓÃ˽ÈËͨÐŵÄÊéÃæÍ¬Òâ²ÄÁϵĸ´Ó¡¼þ •ÓÐЩÆÚ¿¯ÒªÇ󸽸å¼þ¶ÔÕÕ¼ì²é±í ÒÔÉϲÄÁϲ»ÒªÓö©Ê鶤¹Ì¶¨£¬ÒÔÃâ;ÖÐÒò¶©Êé¶¤ÒÆ¶¯¶øË𻵸å¼þ£»µ«¿ÉÒÔÓôóÐÍÇú±ðÕë¹Ì¶¨£¬ÕÕÆ¬¿ÉÒÔÔÚÐÅ·âÖмÐӲֽƬ±£»¤¡£ ¸å¼þÓÊ¼Ä Óʼĸå¼þӦעÒ⣺ •Ó¦ÖÁÉÙ×ÔÁôÒ»·Ý´òÓ¡µ×¸å •ÐÅ·âÒª×ã¹»´ó£¬²¢×ã¹»½áʵ •ÕýÈ·µÄͶ¸åµØÖ·¼°ÊÕ¸åÈË£¨¡°Í¶¸åÐëÖª¡±Öг£ÓÐ˵Ã÷£¬¶àÒªÇóÖ±½Ó¼Ä¸øÖ÷±à£© •ÕÕÆ¬²»¿É¹ý´ó£¬×î´ó²»³¬¹ý8.5Ó¢´çx11Ó¢´ç•Ìù×ãÓÊÆ± •º½¿ÕÓÊ¼Ä •ÒÔ´òÓ¡¸å£¨hard copy£©Í¶¸å ¼¸ºõËùÓеÄÓ¢ÎÄÉúÎïҽѧÆÚ¿¯¾ù²»½ÓÊÜ´«Õæ(fax)Ͷ¸å£¬Ä³Ð©ÆÚ¿¯½öÔÊÐíһЩûÓÐͼ±íµÄ¶ÌÎÄ»ò¡°¸ø±à¼µÄÐÅ¡±Í¨¹ýµç×ÓÓʼþ£¨e-mail£©Í¶¸å£¬³¤ÆªÂÛÖø¡¢Ñо¿±¨¸æµÈÎÄÕ¾ö¶¨¿¯Óú󷽽ÓÊÜÈí´ÅÅÌ¡£ÒÔÉÏÐÅÏ¢¿ÉÒÔ´Ó¡°Í¶¸åÐëÖª¡±ÖлñµÃ¡¢ÓÐµÄÆÚ¿¯ÔÚ¡°Í¶¸åÐëÖª¡±ÖÐÌØ±ðÖ¸³öͶ¸åµØÖ·Óë¶©¿¯»ò¶©µ¥Ðб¾µÄµØÖ·²»Ò»Ñù£¬×÷ÕßÓ¦ÌØ±ð×¢Ò⣬ÒÔÃâÔì³É²»±ØÒªµÄʱ¼äµ¢¸é ¡£ |
7Â¥2005-04-18 10:15:18
ÂÛÎÄͶ¸å×¢ÒâÊÂÏî
|
¹úÍâ¿ÆÑ§½çÓÐÒ»¾äÃûÑÔ£ºÒ»Ïî¿ÆÑ§ÊµÑ飬ֱµ½Æä³É¹û·¢±í²¢±»Àí½â²ÅËãÍê³É¡£´ËÃûÑÔ²ûÊöÁËÁ½¸öµÀÀí£¬Ê×ÏÈÊÇÑо¿³É¹û±ØÐë·¢±í£¬¼´ÐÅÏ¢µÃµ½´«²¥ºÍ½»Á÷£»Æä´ÎÊÇ·¢±íµÄÂÛÎıØÐë±»¶ÁÕß½ÓÊܲ¢Àí½â£¬¼´ÐÅÏ¢±»Éç»áÈϿɣ¬²úÉúÁËÓ¦ÓеÄÉç»áÐ§ÒæºÍ¾¼ÃÐ§Òæ¡£ ¾Ý¡¶ÃÀ¹úҽѧ»áÔÓÖ¾¡·£¨Journal of the American Medical Association , JAMA£©Í³¼Æ£º1996JAMA¹ú¼ÊͶ¸åռȫ²¿×ÔÓÉÀ´¸åµÄ13%£¬½ÓÊÜÂʽöΪ£¨¹ú¼ÊͶ¸åµÄ£©8%£¬ÆäÖÐÓ¢¹úͶ¸å53ƪ£¬½ÓÊÜ9ƪ£»°Ä´óÀûÑÇͶ¸å20ƪ£¬½ÓÊÜ3ƪ£»¼ÓÄôóͶ¸å109ƪ£¬½ÓÊÜ19ƪ£»¡¡Öйú½öͶ¸å4ƪ£¬½ÓÊÜ0ƪ¡£1997JAMA¹ú¼ÊͶ¸åռȫ²¿×ÔÓÉÀ´¸åµÄ14%£¬½ÓÊÜÂÊΪ9%£¬ÆäÖÐÓ¢¹úͶ¸å33ƪ£¬½ÓÊÜ4ƪ£»°Ä´óÀûÑÇͶ¸å16ƪ£¬½ÓÊÜ1ƪ£»¼ÓÄôóͶ¸å100ƪ£¬½ÓÊÜ19ƪ£»¡¡Öйú½öͶ¸å6ƪ£¬½ÓÊÜ0ƪ¡£ÒÔÉÏÊý¾Ý´ÓÒ»¸ö²àÃæ±íÃ÷£¬ËäȻĿǰÎÒ¹úÉúÎïҽѧ¹¤×÷ÕßÕýÔÚ½øÐлòÒѾÍê³ÉÁË´óÁ¿µÄ¹ú¼ÊˮƽµÄÑо¿¹¤×÷£¬µ«ÓëÎ÷·½¹ú¼Ò±È½Ï£¬Æä³É¹ûÏò¹úÍâÉúÎïҽѧÆÚ¿¯Í¶¸åµÄ±ÈÂÊÈԺܵͣ¬¿¯ÓÃÂÊÔò¸üµÍ¡£ÆäÖ÷ÒªÔÒò³ýÁËÓëÎÒ¹úÉúÎïҽѧ¹¤×÷ÕßÓ¢ÎÄÂÛÎÄд×÷ˮƽÓйØÍ⣻»¹ÓëÎÒ¹ú´ó¶àÊýÉúÎïҽѧ¹¤×÷Õß²»Á˽â¹úÍâÉúÎïҽѧÆÚ¿¯µÄ±à¼Õþ²ßºÍ±ê×¼¡¢²»Á˽âÏò¹úÍâÉúÎïҽѧÆÚ¿¯Í¶¸åµÄ³ÌÐò£¬ÒÔÖ²»¸ÒÏò¹úÍâͶ¸å»òËùͶ¸å¼þ²»·ûºÏ¹úÍâÉúÎïҽѧÆÚ¿¯µÄÒªÇóÓкܴó¹ØÏµ¡£ ΪÁËʹÎÒ¹úÉúÎïҽѧ¹¤×÷ÕßÄÜÔÚ¹úÍâÉúÎïҽѧÆÚ¿¯£¬ÓÈÆäÊÇÔÚ¹ú¼ÊÖøÃûÆÚ¿¯ÉÏ·¢±í¸ü¶àµÄ¸ßˮƽÂÛÎÄ£¬Ê¹ÆäËü¹ú¼ÒµÄÉúÎïҽѧ¿ÆÑ§¼Ò¸ü¶à¡¢¸üºÃµØÁ˽âÖйú£¬Ìá¸ßÎÒ¹úÔÚ¹ú¼ÊÉúÎïҽѧÁìÓòµÄµØÎ»£¬ÎÒ¹úÉúÎïҽѧ¹¤×÷ÕßӦŬÁ¦Ìá¸ß×Ô¼ºµÄÓ¢ÎÄд×÷¼¼ÄÜ¡¢ÈÏÕæÑ§Ï°¹úÍâÉúÎïҽѧÆÚ¿¯±àÅŵĹú¼Ê±ê×¼¡¢ÊìϤ¹úÍâÉúÎïҽѧÆÚ¿¯ÂÛÎĵķ¢±í¹ý³Ì£¬²¢Á˽âÈçºÎ»ñµÃ¹úÍâÉúÎïҽѧÆÚ¿¯±à¼µÄ°ïÖú¡£ |
2Â¥2005-04-18 10:10:44
ÕýÈ·Ñ¡ÔñÆÚ¿¯
|
¾Ý¹À¼Æ£¬Ä¿Ç°Î÷·½¹ú¼ÒÓм¸Ç§ÖÖÓ¢ÎÄÉúÎïҽѧÆÚ¿¯£»¶ø¹ú¼ÊÖøÃûÉúÎïҽѧÆÚ¿¯×ÔÓÉÀ´¸åµÄÍ˸åÂʾùÔÚ90%×óÓÒ¡£ ÎÒ¹úÉúÎïҽѧ¹¤×÷ÕßֻҪȷÐÅ×Ô¼ºµÄÑо¿³É¹ûÒÑ´ïµ½ÔÚ¹úÍâÉúÎïҽѧÆÚ¿¯·¢±íµÄˮƽ£¬¼´¾ßÓÐÍ»³öµÄ¿ÆÑ§ÖØÒªÐÔ¡¢ÄÜÒýÆðÓйØÑ§¿Æ¶ÁÕߵļ«´óÐËȤ£¬¾ÍÓпÉÄÜÔÚÒÔÉÏÁ½¸öÊý×ÖÖ®¼äÕÒµ½Ò»ÖÖÊʺÏÓÚ×Ô¼ºÂÛÎÄͶ¸åµÄÆÚ¿¯¡£Õâʱ£¬ÎÒÃÇËùÒª×÷µÄÒ»ÇоÍÊÇÕÒµ½Õâ±¾¿¯Î²¢°´Æä¸ñʽ׫дÂÛÎÄ£¬ÒòΪÍ˸峣³£½öÊÇÒòΪÂÛÎIJ»ÊʺÏÓÚËùͶÆÚ¿¯µÄÕ÷¸å·¶Î§»ò¸ñʽҪÇó¡£ ¹úÍâÓ¢ÎÄÉúÎïҽѧÆÚ¿¯ÖÖÀà·±¶à£¬¼´Ê¹ÔÚͬһ·Ö֧ѧ¿Æ»òͬһÁÙ´²×¨ÒµÒ²ÓÐÐí¶àÆÚ¿¯£¬²¢ÇÒ¸÷¸öÆÚ¿¯µÄ°ì¿¯×ÚÖ¼¡¢×¨Òµ·¶Î§¡¢Ö÷Ìâ·ÖÅä¡¢À¸Ä¿ÉèÖü°¸÷ÖÖÀàÐÍÎÄÕ·¢±íµÄ±ÈÀý¾ù²»Ïàͬ¡£Òò´Ë£¬Ñ¡ÔñÒ»±¾Ç¡µ±µÄÆÚ¿¯²¢·ÇÒ»¼þÒ×Ê£¬³£³£Òª»¨·Ñ½Ï¶àµÄʱ¼ä£¬È»¶øÕâÊÇÂÛÎÄд×÷ǰ±Ø²»¿ÉÉÙµÄÖØÒªÒ»²½£¬ÊÇÂÛÎĵÃÒÔ·¢±íµÄÒ»¸ö¼«ÆäÖØÒªµÄ»·½Ú¡£ ÂÛÎÄËùͶÆÚ¿¯²»ÕýÈ·»ò²»ºÏÊÊ£¬³£»á·¢ÉúÒÔÏÂÈýÖÖÇé¿öÖеÄÈκÎÒ»ÖÖ£º µÚÒ»£¬Í˸塣¸å¼þ½öÒÔ¡°²»ºÏ±¾¿¯ÒªÇó¡±±»¼òµ¥µÄÍ˻ء£È»¶øÒòÍ˸å¾ö¶¨³£ÔÚ¸å¼þ±»ÉóÔĺó×÷³ö£¬Òò´Ëʱ¼äÒѾµ¢¸éÁ˼¸¸öÐÇÆÚ»ò¼¸¸öÔ¡£ µÚ¶þ£¬Éó¸å»òÍËÐÞÒâ¼û²»Ç¡µ±¡£µ±¸å¼þÄÚÈݲ»ÊÇËùͶÆÚ¿¯µÄÖ÷Ҫרҵ·½Ïòʱ£¬ÓÉÓÚÉó¸åÈË£¨»ò±à¼£©¶Ô¸å¼þËùÉæ¼°µÄרҵ²»ÊìϤ¡¢ËÆÊǶø·Ç£¬Òò´Ë¿ÉÄÜ×÷³ö²»×¼È·»ò²»¹«ÕýµÄÉó¸åÒâ¼û£¬ÒÔÖÂʹ×÷ÕßÊÕµ½ÎÞ·¨½ÓÊÜ¡¢ÇÒ²»ÀûÓÚÌá¸ß¸å¼þÖÊÁ¿µÄÍËÐÞÒâ¼û»ò³ÐÊÜÍ˸åµÄ´ò»÷£¨¼´Ê¹¸å¼þ¿ÉÄÜÒÔºó±»ÆäËüºÏÊʵĿ¯Îï½ÓÊÜ£©¡£µ±¸å¼þȷʵ´æÔÚijЩȱÏÝ»ò²»×ãʱ£¬×÷ÕßÒ²²»¿ÉÄÜ´Ó±à¼ÄÇÀïµÃµ½ÓÐÒæµÄ½¨ÉèÐÔÍËÐÞÒâ¼û¡£ µÚÈý£¬Éç»áÐ§ÒæµÍ¡£µ±ËùͶÆÚ¿¯ÊǸå¼þÉæ¼°×¨ÒµÁìÓòÍâµÄ¿¯Î¼´Ê¹ÎÄÕ±»½ÓÊܲ¢·¢±íÁË£¬µ«ÓÉÓÚͬÐв¢²»ÉæÁԸÿ¯ÎÒò´Ë×÷ÕßµÄÑо¿³É¹û¼¸ºõ²»Îª±¾×¨ÒµµÄ¶ÁÕßËùÖª¡£ |
3Â¥2005-04-18 10:11:24
Ñ¡ÔñÆÚ¿¯Ó¦¿¼ÂǵÄÒòËØ
|
ÆÚ¿¯µÄרҵ·¶Î§£¨scope£©¼°ÂÛÎĸñʽ(format) ×÷ÕßÊ×ÏÈӦȷ¶¨×Ô¼ºµÄÂÛÎÄÖ÷ÌâÊÇ·ñÔÚ¿¯ÎïµÄÕ÷¸å·¶Î§ÄÚ¼°ÂÛÎÄ׫д¸ñʽÊÇ·ñÓ뿯ÎïµÄÒªÇóÒ»Ö£¬Èç¹û´ð°¸ÊÇ¡°·ñ¡±£¬ÔòÓ¦Á¢¼´Í£Ö¹¶Ô¸Ã¿¯ÎïµÄ½øÒ»²½¡°Ñо¿¡±£¬¶øÓ¦È¥Ñ°ÕÒÆäËü¿ÉÄܵĿ¯Îï¡£ÄâͶÂÛÎÄ¿ÉÄܼ«ÎªÓÅÐ㣬µ«Èç¹û²»ÊʺÏÓڸÿ¯ÎÔò²»¿ÉÄÜÔڸÿ¯Îï±»·¢±í¡£ ÆÚ¿¯µÄÉùÍû(prestige) ÆÚ¿¯µÄѧÊõˮƽ¸ß£¬ÆäÉùÍû¾Í¸ß£»·´Ö®£¬ÉùÍûÔòµÍ¡£¸÷¹úÉúÎïҽѧ¹¤×÷Õß¶¼Ï£Íû×Ô¼ºµÄ¿ÆÑгɹûÄܹ»·¢±íÔÚÓÐÉùÍûµÄ¸ßÖÊÁ¿µÄÉúÎïҽѧÆÚ¿¯ÉÏ¡£ÒòΪÉùÍû¸ßµÄÆÚ¿¯ÓÐÀûÓÚÐÅÏ¢µÄ¹ú¼Ê¼ä´«²¥ºÍ½»Á÷£¬²¢¶ÔѧÊõ³É¹ûµÄÈϿɾßÓÐȨÍþÐÔ¡£È»¶øÊÀ½çÉÏ×îÓÐÉùÍûÆÚ¿¯µÄÍ˸åÂÊÒ²ºÜ¸ß£¬Æä×ÔÓÉÀ´¸åµÄÍ˸åÂÊÒ»°ã¾ùÔÚ85%£90%£¬ÆäÖв»·¦Ðí¶à½Ü³ö¿ÆÑ§¼ÒµÄ¸ßÖÊÁ¿ÂÛÎÄ£¬ÈçScience, Nature¡¢New England Journal of Medicine£¨New Engl J Med£©¡¢Lancet¡¢JAMAµÈ¡£Òò´Ë£¬Ñ¡ÔñÆÚ¿¯Ò»¶¨Òª¸ù¾Ý×Ô¼ºÂÛÎĵÄʵ¼ÊˮƽÕýÈ·¶¨Î»£¬²»¿Éһζ׷Çó×îÓÐÉùÍûµÄÆÚ¿¯¡£³ý¶À´´ÐԵĿÆÑгɹû¿ÉÑ¡Ôñ¹ú¼Ê¶¥¼âÉúÎïҽѧÆÚ¿¯Í⣬ÆäËü¿ÆÑÐÂÛÎÄÓ¦ÔÚ¸å¼þ¿É½ÓÊÜÂÊÖÁÉÙΪ30%ÒÔÉÏµÄÆÚ¿¯ÖÐÑ¡ÔñѧÊõÖÊÁ¿¸ßµÄÆÚ¿¯Í¶¸å¡£ ÃÀ¹úÖݺ͵ØÇøÐÔÆÚ¿¯×îÈÝÒ×±»×÷ÕߺöÂÔ£¬×÷ÕßÍùÍù½ö¿¼ÂÇÓ¢ÃÀ¹ú¼ÒÖøÃûÆÚ¿¯¡£ÆäʵÔÚ¶àÊýÇé¿öÏ£¬ÃÀ¹úÖݺ͵ØÇøÐÔ¿¯ÎïÒ²»áÊܵ½¶ÁÕßͬÑùµÄ×ðÖØ£¬²¢ÇÒÕâЩ¿¯ÎïµÄ×ÔÓÉÀ´¸åÔ¶Ô¶µÍÓÚÓ¢ÃÀ¹ú¼ÒÖøÃûÆÚ¿¯£¬Òò´Ë¶ÔÎÒ¹ú×÷ÕߺÏÊÊµÄÆÚ¿¯²»Ò»¶¨ÊÇÓ¢ÃÀ¹ú¼ÒÖøÃûµÄÉúÎïҽѧÆÚ¿¯¡£ÏÂÃæ4ÖÖÃÀ¹úÖݺ͵ØÇøÐÔÆÚ¿¯¿É¹©ÎÒÃÇÑ¡ÔñÆÚ¿¯Ê±¿¼ÂÇ£º •Î÷²¿Ò½Ñ§ÔÓÖ¾£¨Western Journal of Medicine£©•Äϲ¿Ò½Ñ§ÔÓÖ¾£¨Southern Medical Journal£© •µÃ¿ËÈøË¹ÐÄÔàÑо¿ËùÔÓÖ¾£¨Texas Heart Institute Journal £©•ŦԼÖÝҽѧÔÓÖ¾£¨New York State Journal of Medicine£© ÆÚ¿¯ÂÛÎĵijö°æÊ±ÖÍ£¨publication lag£© ÂÛÎÄ´Ó½ÓÊܵ½·¢±íµÄƽ¾ùʱ¼ä£¬¼´³ö°æÊ±ÖÍÊÇ×÷ÕßÑ¡ÔñÆÚ¿¯Ê±Ð迼ÂǵÄÒ»¸öÖØÒªÎÊÌâ¡£ÂÛÎĵijö°æÊ±ÖÍÓëÆÚ¿¯µÄ³ö°æÖÜÆÚ¼°¸å¼þ»ýѹ£¨backlogs£©Çé¿öÃÜÇÐÏà¹Ø¡£¹úÍâÓ¢ÎÄÉúÎïҽѧÆÚ¿¯¶àΪÔ¿¯£»ÖøÃûµÄ×ÛºÏÐÔҽѧÆÚ¿¯¾ùΪÖÜ¿¯£¬ÈçJAMA, New Engl J Med, LancetºÍBritish Medical Journal( BMJ)ËÄ´óÖøÃûÖÜ¿¯£»Ë«Ô¿¯½ÏÉÙ£»¼¾¿¯Ôò¸üÉÙ¡£Ò»°ãÀ´Ëµ£¬ÔÚ¸å¼þ»ýѹÏàËÆµÄÇé¿öÏ£¬Ô¿¯µÄ³ö°æÊ±ÖÍ×ÜÊǶÌÓÚ˫Կ¯¼°¼¾¿¯£¬¼´Ô¿¯µÄÐÅϢʱЧÐÔÓÅÓÚ˫Կ¯ºÍ¼¾¿¯¡£È»¶ø£¬Ðí¶àÆÚ¿¯£¬ÎÞÂÛÊÇÔ¿¯¡¢Ë«Ô¿¯£¬»¹ÊǼ¾¿¯¾ùÓиå¼þ»ýѹ¡£ÆÚ¿¯¸å¼þ»ýѹԽ¶à£¬ÆäÂÛÎĵijö°æÊ±ÖÍÔ½³¤£»·´Ö®£¬³ö°æÊ±ÖÍÔ½¶Ì¡£Òò´Ë£¬×÷ÕßÐèÒªÁ˽âÄâͶÆÚ¿¯ÂÛÎĵijö°æÊ±ÖÍ£¬ÒÔÈ·¶¨×Ô¼ºµÄÂÛÎÄÊÇ·ñ¿ÉÒÔµÈ1Ä꣬ÉõÖÁ2Äê²ÅÄÜ·¢±í¡£ ¶ÔÓÚд´¿¯µÄÔÓÖ¾£¬ÓÈÆäÊÇÄÇЩÎÞÉç»áÔÞÖúµÄÆÚ¿¯£¬Ò»°ãÈÏΪÆäÓ°ÏìÒò×ӵ͡¢·¢ÐÐÁ¿Ð¡£¬ºÜÄÑά³ÖÏÂÈ¥¡£È»¶øÎÒÃDz»Ó¦ºöÊÓ»ò·ÅÆúÈκÎÐÂÆÚ¿¯£¬ÒòΪÐÂÆÚ¿¯ÎÞ¸å¼þ»ýѹ£¬²¢ÇÒ×ÜÊÇÔÚѰÇó¸ßÖÊÁ¿µÄѧÊõÂÛÎÄÒÔ²»¶ÏÌá¸ß¿¯ÎïµÄÉùÍû£¬Òò´Ë½«ÂÛÎÄͶµ½ÐÂÆÚ¿¯£¬±»½ÓÊܵĻú»á¿ÉÄܸü¶à¡¢±»·¢±íµÄËÙ¶È¿ÉÄܸü¿ì¡£ ÆÚ¿¯µÄ¶ÁÕßȺ£¨audience£© ÔÚÑ¡ÔñÆÚ¿¯Ê±±ØÐ뿼ÂÇÄâͶ¿¯ÎïµÄ¶ÁÕßÊÇ·ñΪÂÛÎÄÆÚÍû´ïµ½µÄ¶ÁÕßȺ£¬¼´ÊÇÄãµÄÄ¿±ê¶ÁÕß¡£ËùÓеÄд×÷Õߣ¬°üÀ¨¿ÆÑ§¼ÒÔÚÄÚ£¬ËûÃÇд×÷ʱ¶¼±ØÐëʱ¿ÌÏë×ÅËûÃǵĶÁÕß¡ª¶ÁÕß½«ÊÇË£¿ÎªÊ²Ã´ËûÃÇÏë¶ÁÎÒµÄÎÄÕ£¿Ïë¶ÁÕßÓÐÖúÓÚÕýÈ·Ñ¡ÔñͶ¸åÆÚ¿¯£»¶øÄ¿±êÆÚ¿¯µÄÈ·¶¨£¬ÓÖÄÜʹ×÷Õ߸üÁ˽â˽«ÊÇ×Ô¼ºµÄ¶ÁÕߣ¬²¢ÄÜÓÃÓÚÖ¸µ¼Ð´×÷¡£ ÆÚ¿¯µÄ·¢ÐÐÁ¿(circulation) ÆÚ¿¯µÄ·¢ÐÐÁ¿´ó£¬±íÃ÷ÆäÐÅÏ¢´«²¥µÄ·¶Î§¹ã£¬Ó°ÏìÃæ´ó£¬±»Éç»áÈϿɵij̶ȸߡ£È»¶ø¶Ô·¢ÐÐÁ¿Ò»¶¨Òª±æÖ¤µØ·ÖÎö£¬²»¿É¾ø¶Ô»¯¡£Èç¹û×÷ÕßËù´ÓÊµĹ¤×÷½öÏÞÓÚÒ»¸öºÜÕµÄÑо¿ÁìÓò£¬ÆäËùÊÊÓÚͶ¸åµÄÆÚ¿¯µÄ·¢ÐÐÁ¿ËäÈ»ºÜС£¬µ«È·ÊÇ×÷ÕßËùÏ£Íû´ïµ½µÄ¶ÁÕßȺ£¬ÄÇôÕâ¸öÆÚ¿¯¾ÍÊÇ×÷ÕßͶ¸åµÄ×î¼ÑÑ¡Ôñ¡£ ÂÛÎĵijö°æ·ÑÓã¨payments£© ¹úÍâÓ¢ÎÄÉúÎïҽѧÆÚ¿¯ÊÕÈ¡ÂÛÎÄ·¢±í·Ñ£¨page charges£©¼°²Êͼ·Ñ£¨cost of color photographs£©µÄÕþ²ß²»¾¡Ïàͬ£¬ÓÐµÄÆÚ¿¯²»ÊÕ·¢±í·Ñ£¬Ò²²»ÊÕ²Êͼ·Ñ£»ÓÐµÄÆÚ¿¯²»ÊÕ·¢±í·Ñ£¬µ«ÊÕ²Êͼ·Ñ£»ÓÐµÄÆÚ¿¯¼ÈÊÕ·¢±í·ÑÒ²ÊÕ²Êͼ·Ñ£»È»¶øÄ³Ð©ÆÚ¿¯ÔÚ×÷ÕßÌá³öºÏÊʵÄÀíÓɺ󣬿ÉÒÔÃâÊÕÒÔÉÏ·ÑÓᣵ«¼¸ºõËùÓÐµÄÆÚ¿¯¾ùÊÕÈ¡µ¥Ðб¾·ÑÓá£ÔÚÃÀ¹ú£¬Ðí¶àÉúÎïҽѧÑо¿Óлù½ð×ÊÖú£¬Òò´ËÑо¿ÂÛÎĵķ¢±í·Ñ¼°²Êͼ·Ñ¿ÉÓÉ»ù½ðÖ§¸¶¡£¶ø¶ÔÓÚÎÞ»ù½ð×ÊÖú»òÓлù½ð×ÊÖúµ«ÎÞÍâ»ãµÄÎÒ¹úÉúÎïҽѧ¹¤×÷Õߣ¬ÔÚÑ¡ÔñÆÚ¿¯Ê±Ò»¶¨ÒªÁ˽âÇå³þÄâͶÆÚ¿¯µÄ¸÷ÖÖÊÕ·ÑÕþ²ß£¬ÒÔÃâÔì³ÉÈÕºóµÄÞÎÞÏ¡£ |
4Â¥2005-04-18 10:12:07













»Ø¸´´ËÂ¥